Corporate Members
The Pennsylvania Society of Oncology and Hematology expresses its gratitude to our corporate members. Donations from the following companies help us in fulfilling our mission.
To learn more about becoming a Corporate Member, please click here.
To learn more about becoming a Corporate Member, please click here.
10k Members
Daiichi-Sankyo
About us:
The mission of Daiichi Sankyo Cancer Enterprise is to leverage our world-class, innovative science and push beyond traditional thinking to create meaningful treatments for patients with cancer. We are dedicated to transforming science into value for patients, and this sense of obligation informs everything we do. Anchored by our DXd antibody drug conjugate (ADC) technology, our powerful research engines include biologics, medicinal chemistry, modality and other research laboratories in Japan, and Plexxikon Inc., our small molecule structure-guided R&D center in Berkeley, CA. For more information, please visit: www.DSCancerEnterprise.com.
Website:
www.DSCancerEnterprise.com ; www.dsi.com
Representative Contact:
Darren Geissler, dgeissler1@dsi.com, 717-903-8948
Social Media:
Twitter: https://twitter.com/DaiichiSankyoUS
LinkedIn: https://www.linkedin.com/company/daiichi-sankyo/
The mission of Daiichi Sankyo Cancer Enterprise is to leverage our world-class, innovative science and push beyond traditional thinking to create meaningful treatments for patients with cancer. We are dedicated to transforming science into value for patients, and this sense of obligation informs everything we do. Anchored by our DXd antibody drug conjugate (ADC) technology, our powerful research engines include biologics, medicinal chemistry, modality and other research laboratories in Japan, and Plexxikon Inc., our small molecule structure-guided R&D center in Berkeley, CA. For more information, please visit: www.DSCancerEnterprise.com.
Website:
www.DSCancerEnterprise.com ; www.dsi.com
Representative Contact:
Darren Geissler, dgeissler1@dsi.com, 717-903-8948
Social Media:
Twitter: https://twitter.com/DaiichiSankyoUS
LinkedIn: https://www.linkedin.com/company/daiichi-sankyo/
Exelixis, Inc.
About us:
Founded in 1994, Exelixis, Inc. (Nasdaq: EXEL) is a biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines. To ensure you have the latest clinical data, including links to our pivotal trial publications, and important product information, visit our website.
Website:
https://www.exelixis.com
Representative:
Michael Nozzi
Senior Oncology Account Manager
570-357-1906
mnozzi@exelixis.com
Founded in 1994, Exelixis, Inc. (Nasdaq: EXEL) is a biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines. To ensure you have the latest clinical data, including links to our pivotal trial publications, and important product information, visit our website.
Website:
https://www.exelixis.com
Representative:
Michael Nozzi
Senior Oncology Account Manager
570-357-1906
mnozzi@exelixis.com
Gilead
About Us: Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved milestones in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to developing and advancing innovative medicines to prevent and treat life-threatening diseases. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com. © 2022 Gilead Sciences, Inc. All rights reserved. -
Website: www.gilead.com
Representative Contacts: Nicole Cornett – Regional Business Director – Nicole.Cornett@gilead.com - 201 341-4605
Website: www.gilead.com
Representative Contacts: Nicole Cornett – Regional Business Director – Nicole.Cornett@gilead.com - 201 341-4605
Janssen
Merck
Social Media:
LinkedIn: linkedin.com/company/Merck
Facebook: www.facebook.com/Merckinvents
Twitter: twitter.com/Merck
Instagram: instagram.com/Merck
YouTube: youtube.com/user/Merck
LinkedIn: linkedin.com/company/Merck
Facebook: www.facebook.com/Merckinvents
Twitter: twitter.com/Merck
Instagram: instagram.com/Merck
YouTube: youtube.com/user/Merck
Regeneron
About Us:
Regeneron is a leading science-based biopharmaceutical company that invents, develops and commercializes medicines to treat serious medical conditions.
Website: www.regeneron.com
Representative Contacts:
Paul Scharf - Key Account Leader paul.scharf@regeneron.com
Melissa Taylor – Reimbursement Business Manager melissa.taylor@regeneron.com
Selena Kent - Senior Oncology Account Specialist – Selena.kent@regeneron.com
John Honus – Oncology Account Specialist - John.honus@regeneron.com
Josette Gephart – Oncology Account Specialist – Josette.gephart@regeneron.com
Jacqueline Matthews – Oncology Account Specialist – Jacqueline.matthews@regeneron.com
Brandy Kurrell – Oncology Account Specialist - Brandy.kurrell@regeneron.com
Reimbursement Link: https://www.libtayohcp.com/libtayo-surround
Social Media Links:
Facebook: https://www.facebook.com/Regeneron/
Twitter: https://twitter.com/Regeneron?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor
LinkedIn: https://www.linkedin.com/company/regeneron-pharmaceuticals
Instagram: https://www.instagram.com/regeneron/?hl=en
Regeneron is a leading science-based biopharmaceutical company that invents, develops and commercializes medicines to treat serious medical conditions.
Website: www.regeneron.com
Representative Contacts:
Paul Scharf - Key Account Leader paul.scharf@regeneron.com
Melissa Taylor – Reimbursement Business Manager melissa.taylor@regeneron.com
Selena Kent - Senior Oncology Account Specialist – Selena.kent@regeneron.com
John Honus – Oncology Account Specialist - John.honus@regeneron.com
Josette Gephart – Oncology Account Specialist – Josette.gephart@regeneron.com
Jacqueline Matthews – Oncology Account Specialist – Jacqueline.matthews@regeneron.com
Brandy Kurrell – Oncology Account Specialist - Brandy.kurrell@regeneron.com
Reimbursement Link: https://www.libtayohcp.com/libtayo-surround
Social Media Links:
Facebook: https://www.facebook.com/Regeneron/
Twitter: https://twitter.com/Regeneron?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor
LinkedIn: https://www.linkedin.com/company/regeneron-pharmaceuticals
Instagram: https://www.instagram.com/regeneron/?hl=en
Seagen Inc.
About Us:
Seagen Inc. is a global biotechnology company that discovers, develops, and commercializes medicines for cancer. The company has a pipeline of therapies at various stages of preclinical testing, clinical testing, and development. We are leveraging our expertise in antibodies to build a portfolio of proprietary immuno-oncology agents in clinical trials for hematologic malignancies and solid tumors. For more information, visit www.seagen.com.
Click here to learn more.
Website:
www.seagen.com; https://www.seagen.com/medicines
Social Media:
LinkedIn: https://www.linkedin.com/company/seagen
Twitter: https://twitter.com/seagenglobal
Seagen Inc. is a global biotechnology company that discovers, develops, and commercializes medicines for cancer. The company has a pipeline of therapies at various stages of preclinical testing, clinical testing, and development. We are leveraging our expertise in antibodies to build a portfolio of proprietary immuno-oncology agents in clinical trials for hematologic malignancies and solid tumors. For more information, visit www.seagen.com.
Click here to learn more.
Website:
www.seagen.com; https://www.seagen.com/medicines
Social Media:
LinkedIn: https://www.linkedin.com/company/seagen
Twitter: https://twitter.com/seagenglobal
5k Members
AbbVie
About Us:
At AbbVie, we strive to discover and develop medicines that deliver transformational improvements in
cancer treatment by uniquely combining our deep knowledge in core areas of biology with cutting-edge
technologies, and by working together with our partners – scientist, clinical experts, industry peers, advocates, and patients. We remain focused on delivering these transformative advances in treatment across some of the most debilitating and widespread cancers. We are also committed to exploring solutions to help patients obtain access to our cancer medicines. AbbVie’s oncology portfolio now consists of marketed medicines and a pipeline containing multiple new molecules being evaluated worldwide in more than 300 clinical trials and more than 20 different tumor types. For more information, please visit http://www.abbvie.com/oncology.
Website:
https://www.abbvie.com/science/areas-of-focus/oncology.html
Representatives:
Sara Orndoff-Snyder: sara.orndoff@abbvie.com 412.335.0449
Faith Stanton: faith.stanton@abbvie.com 267.767.4394
Eileen Button: Eileen.button@abbvie.com 215.806.5619
Courtney Tomeo: Courtney.tomeo@abbvie.com 862.260.5172
Tyler Pinney: tyler.pinnery@abbvie.com 609.760.8417
Social Media
@abbvie on
https://twitter.com/abbvie
https://www.facebook.com/AbbVieGlobal/
https://www.youtube.com/user/AbbVie
https://www.linkedin.com/company/abbvie/mycompany/verification/
At AbbVie, we strive to discover and develop medicines that deliver transformational improvements in
cancer treatment by uniquely combining our deep knowledge in core areas of biology with cutting-edge
technologies, and by working together with our partners – scientist, clinical experts, industry peers, advocates, and patients. We remain focused on delivering these transformative advances in treatment across some of the most debilitating and widespread cancers. We are also committed to exploring solutions to help patients obtain access to our cancer medicines. AbbVie’s oncology portfolio now consists of marketed medicines and a pipeline containing multiple new molecules being evaluated worldwide in more than 300 clinical trials and more than 20 different tumor types. For more information, please visit http://www.abbvie.com/oncology.
Website:
https://www.abbvie.com/science/areas-of-focus/oncology.html
Representatives:
Sara Orndoff-Snyder: sara.orndoff@abbvie.com 412.335.0449
Faith Stanton: faith.stanton@abbvie.com 267.767.4394
Eileen Button: Eileen.button@abbvie.com 215.806.5619
Courtney Tomeo: Courtney.tomeo@abbvie.com 862.260.5172
Tyler Pinney: tyler.pinnery@abbvie.com 609.760.8417
Social Media
@abbvie on
https://twitter.com/abbvie
https://www.facebook.com/AbbVieGlobal/
https://www.youtube.com/user/AbbVie
https://www.linkedin.com/company/abbvie/mycompany/verification/
Amgen
About Us:
At Amgen Oncology, our mission to serve patients drives all that we do. That's why we're relentlessly focused on accelerating the delivery of medicines that have the potential to empower all angles of care and transform lives of people with cancer. For the last four decades, we have been dedicated to discovering the firsts that matter in oncology and to finding ways to reduce the burden of cancer. Building on our heritage, Amgen continues to advance the largest pipeline in the Company's history, moving with great speed to advance those innovations for the patients who need them.
Website:
www.amgenoncology.com/
Representatives:
Nick Arena
Cell: 609.502.1200;
narena@amgen.com
Social Media:
Twitter: twitter.com/amgenoncology
At Amgen Oncology, our mission to serve patients drives all that we do. That's why we're relentlessly focused on accelerating the delivery of medicines that have the potential to empower all angles of care and transform lives of people with cancer. For the last four decades, we have been dedicated to discovering the firsts that matter in oncology and to finding ways to reduce the burden of cancer. Building on our heritage, Amgen continues to advance the largest pipeline in the Company's history, moving with great speed to advance those innovations for the patients who need them.
Website:
www.amgenoncology.com/
Representatives:
Nick Arena
Cell: 609.502.1200;
narena@amgen.com
Social Media:
Twitter: twitter.com/amgenoncology
Astellas Pharma
About Us:
Astellas Pharma US, Inc. is a U.S. affiliate of Tokyo-based Astellas Pharma Inc., a pharmaceutical conducting business in more than 70 countries around the world. Astellas stands on the forefront of healthcare change to turn innovative science into value for patients. Keeping our focus on addressing unmet medical needs and conducting our business with ethics and integrity enables us to improve the health of people throughout the U.S. and around the world.
Website:
https://www.astellas.com/us
Representative:
Eric Lapham, Senior Access and Reimbursement Manager, Health Systems
Cell/Mobile: 732 245 4232
Eric.Lapham@astellas.com
Social Media:
Twitter at @AstellasUS
Facebook at www.facebook.com/AstellasUS
LinkedIn at www.linkedin.com/company/astellas-pharma-us.
AstraZeneca
About Us:
AstraZeneca focuses on innovative science and leadership in three main therapy areas: Oncology; Cardiovascular, Renal and Metabolism (CVRM); and Respiratory It has a broad R&D platform. It started with small molecules and biologic medicines and is now expanding our platforms with new technologies. With a patient focus, AstraZeneca has a balanced portfolio of specialty and primary care medicines. AstraZeneca Oncology pushes the boundaries of science to change the practice of medicine, transform the lives of patients living with cancer, and ultimately eliminate cancer as a cause of death.
Representative Contact:
Courtney Stanton: Courtney.stanton1@astrazeneca.com
Social Media Links:
Website: https://www.astrazeneca.com/our-therapy-areas/oncology.html#!
Twitter: @AstraZenecaUS
Facebook: AstraZeneca US Community Connections
AstraZeneca focuses on innovative science and leadership in three main therapy areas: Oncology; Cardiovascular, Renal and Metabolism (CVRM); and Respiratory It has a broad R&D platform. It started with small molecules and biologic medicines and is now expanding our platforms with new technologies. With a patient focus, AstraZeneca has a balanced portfolio of specialty and primary care medicines. AstraZeneca Oncology pushes the boundaries of science to change the practice of medicine, transform the lives of patients living with cancer, and ultimately eliminate cancer as a cause of death.
Representative Contact:
Courtney Stanton: Courtney.stanton1@astrazeneca.com
Social Media Links:
Website: https://www.astrazeneca.com/our-therapy-areas/oncology.html#!
Twitter: @AstraZenecaUS
Facebook: AstraZeneca US Community Connections
Aveo
About Us:
AVEO Oncology (“AVEO”) is an oncology-focused biopharmaceutical company committed to providing innovative solutions to improve cancer patients’ lives. On January 20, 2023, AVEO was acquired by LG Chem, Ltd. (“LG Chem”), establishing a U.S. commercial presence for LG Chem and expanding LG Chem’s global oncology portfolio. AVEO continues to commercialize FOTIVDA® (tivozanib) in the U.S. To learn more about FOTIVDA efficacy, safety, and relevant resources, visit FOTIVDAHCP.com.
Website:
https://www.aveooncology.com
Representative:
Jenny Passett – Oncology Account Manager
(716) 713-6708
jpassett@aveooncology.com
Aveo Oncology – 30 Winter Street, Boston, MA 02108
Social Media:
Twitter: https://twitter.com/aveooncology
LinkedIn: https://www.linkedin.com/company/54167?trk=tyah
AVEO Oncology (“AVEO”) is an oncology-focused biopharmaceutical company committed to providing innovative solutions to improve cancer patients’ lives. On January 20, 2023, AVEO was acquired by LG Chem, Ltd. (“LG Chem”), establishing a U.S. commercial presence for LG Chem and expanding LG Chem’s global oncology portfolio. AVEO continues to commercialize FOTIVDA® (tivozanib) in the U.S. To learn more about FOTIVDA efficacy, safety, and relevant resources, visit FOTIVDAHCP.com.
Website:
https://www.aveooncology.com
Representative:
Jenny Passett – Oncology Account Manager
(716) 713-6708
jpassett@aveooncology.com
Aveo Oncology – 30 Winter Street, Boston, MA 02108
Social Media:
Twitter: https://twitter.com/aveooncology
LinkedIn: https://www.linkedin.com/company/54167?trk=tyah
Kyowa Kirin
About us:
Kyowa Kirin strives to create and deliver novel medicines with life-changing value. As a Japan-based Global Specialty Pharmaceutical Company, we apply cutting-edge science and expertise in antibody research and engineering to address the needs of patients and society across multiple therapeutic areas, including Nephrology, Oncology, Immunology/Allergy and Neurology. Across four global regions – Japan, Asia Pacific, North America and EMEA/International – we are united by our shared values of commitment to life, teamwork/Wa, innovation, and integrity, and a drive to advance innovations that have a profound impact on patients. You can learn more about Kyowa Kirin North America at: https://kkna.kyowakirin.com.
Website:
https://kkna.kyowakirin.com
Representative:
Nicole Lesterick, Oncology Account Manager, Kyowa Kirin, Inc., 135 US-202, Bedminster, NJ 07921
Social Media
LinkedIn: Kyowa Kirin, Inc.- U.S.
Twitter: @KyowaKirin_US
YouTube: Kyowa Kirin North America
Kyowa Kirin strives to create and deliver novel medicines with life-changing value. As a Japan-based Global Specialty Pharmaceutical Company, we apply cutting-edge science and expertise in antibody research and engineering to address the needs of patients and society across multiple therapeutic areas, including Nephrology, Oncology, Immunology/Allergy and Neurology. Across four global regions – Japan, Asia Pacific, North America and EMEA/International – we are united by our shared values of commitment to life, teamwork/Wa, innovation, and integrity, and a drive to advance innovations that have a profound impact on patients. You can learn more about Kyowa Kirin North America at: https://kkna.kyowakirin.com.
Website:
https://kkna.kyowakirin.com
Representative:
Nicole Lesterick, Oncology Account Manager, Kyowa Kirin, Inc., 135 US-202, Bedminster, NJ 07921
Social Media
LinkedIn: Kyowa Kirin, Inc.- U.S.
Twitter: @KyowaKirin_US
YouTube: Kyowa Kirin North America
Lilly
About Us:
Lilly unites caring with discovery to create medicines that make life better for people around the world.
We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help
more than 47 million people across the globe. Harnessing the power of biotechnology, chemistry and
genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world’s
most significant health challenges, redefining diabetes care, treating obesity and curtailing its most
devastating long-term effects, advancing the fight against Alzheimer’s disease, providing solutions to
some of the most debilitating immune system disorders, and transforming the most difficult-to-treat
cancers into manageable diseases. With each step toward a healthier world, we’re motivated by one
thing: making life better for millions more people. That includes delivering innovative clinical trials that
reflect the diversity of our world and working to ensure our medicines are accessible and affordable.
To learn more, visit lilly.com and lilly.com/newsroom or follow us on Facebook, Instagram,
and LinkedIn.
Website:
www.lilly.com OR Cancer Medications and Support Programs | Eli Lilly and Company
Representatives:
Kevin Coyne
Senior Regional Oncology Account Manager, Lilly Value and Access
570-406-1548 (mobile)
coyne_kevin_j@lilly.com | www.lilly.com
Social Media:
LinkedIn - https://www.linkedin.com/company/eli-lilly-and-company/
Facebook - https://www.facebook.com/elilillyandco
Instagram: https://www.instagram.com/elilillyco/
Lilly unites caring with discovery to create medicines that make life better for people around the world.
We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help
more than 47 million people across the globe. Harnessing the power of biotechnology, chemistry and
genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world’s
most significant health challenges, redefining diabetes care, treating obesity and curtailing its most
devastating long-term effects, advancing the fight against Alzheimer’s disease, providing solutions to
some of the most debilitating immune system disorders, and transforming the most difficult-to-treat
cancers into manageable diseases. With each step toward a healthier world, we’re motivated by one
thing: making life better for millions more people. That includes delivering innovative clinical trials that
reflect the diversity of our world and working to ensure our medicines are accessible and affordable.
To learn more, visit lilly.com and lilly.com/newsroom or follow us on Facebook, Instagram,
and LinkedIn.
Website:
www.lilly.com OR Cancer Medications and Support Programs | Eli Lilly and Company
Representatives:
Kevin Coyne
Senior Regional Oncology Account Manager, Lilly Value and Access
570-406-1548 (mobile)
coyne_kevin_j@lilly.com | www.lilly.com
Social Media:
LinkedIn - https://www.linkedin.com/company/eli-lilly-and-company/
Facebook - https://www.facebook.com/elilillyandco
Instagram: https://www.instagram.com/elilillyco/
MacroGenics
About Us:
MacroGenics is a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The Company’s flagship product for the treatment of HER2+ metastatic breast cancer was approved by the US Food and Drug Administration in December 2020.
Website: www.macrogenics.com
MacroGenics is a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The Company’s flagship product for the treatment of HER2+ metastatic breast cancer was approved by the US Food and Drug Administration in December 2020.
Website: www.macrogenics.com
Natera
About Us:
Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ
health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health
and inform earlier, more targeted interventions that help lead to longer, healthier lives.
Website: www.natera.com/oncology
Representatives:
Mike Weber, Clinical Oncology Specialist
mweber@natera.com
M: 215-630-6505
Christy Crowell, Clinical Oncology Specialist
ccrowell@natera.com
M: 631-235-5257
Nick Casella, Associate Clinical Oncology Specialist
ncasella@natera.com
M: 609-970-1792
Social Media:
Twitter - https://twitter.com/NateraGenetics
LinkedIn - https://www.linkedin.com/company/natera
Facebook - https://www.facebook.com/NateraGenetics/
Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ
health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health
and inform earlier, more targeted interventions that help lead to longer, healthier lives.
Website: www.natera.com/oncology
Representatives:
Mike Weber, Clinical Oncology Specialist
mweber@natera.com
M: 215-630-6505
Christy Crowell, Clinical Oncology Specialist
ccrowell@natera.com
M: 631-235-5257
Nick Casella, Associate Clinical Oncology Specialist
ncasella@natera.com
M: 609-970-1792
Social Media:
Twitter - https://twitter.com/NateraGenetics
LinkedIn - https://www.linkedin.com/company/natera
Facebook - https://www.facebook.com/NateraGenetics/
Pfizer Oncology
Representatives:
Sue Sproat, CPC, CHONC, CMR, Field Reimbursement Manager - MD, DC, DE, PA
410-627-0807 (cell) | 484-323-7995 (fax)
susan.r.sproat@pfizer.com
Sue Sproat, CPC, CHONC, CMR, Field Reimbursement Manager - MD, DC, DE, PA
410-627-0807 (cell) | 484-323-7995 (fax)
susan.r.sproat@pfizer.com
Sanofi
Website:
www.sanofioncology.com
Representatives:
Nanette Rutherford, Field Reimbursement Manager
724-708-6495
nanette.rutherford@sanofi.com
Social Media:
Facebook: https://www.facebook.com/Sanofi/
LinkedIn: https://www.linkedin.com/company/sanofi
Twitter: https://twitter.com/SanofiUS
Instagram: https://www.instagram.com/sanofi/
CareASSIST Patient Support Information:
www.sanofioncology.com
Representatives:
Nanette Rutherford, Field Reimbursement Manager
724-708-6495
nanette.rutherford@sanofi.com
Social Media:
Facebook: https://www.facebook.com/Sanofi/
LinkedIn: https://www.linkedin.com/company/sanofi
Twitter: https://twitter.com/SanofiUS
Instagram: https://www.instagram.com/sanofi/
CareASSIST Patient Support Information:
